SCHEMBL6203855

SCHEMBL6203855

COc1ccc(CNc2nc(N(CCO)C(C)C)nc3nn[nH]c23)c(O)c1O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNE1 P24864 8/20 0.34
CDK2 P24941 8/20 0.34
PDE5A O76074 3/20 0.34
PDE4D Q08499 3/20 0.34
PDE6C P51160 2/20 0.34
MTOR P42345 1/20 0.34
CCNE2 O96020 5/20 0.33
CCNT1 O60563 3/20 0.33
CDK9 P50750 3/20 0.33
CDK1 P06493 3/20 0.33
CCNB1 P14635 3/20 0.33
CCNA2 P20248 1/20 0.33
CDK7 P50613 1/20 0.33
CCNH P51946 1/20 0.33
MNAT1 P51948 1/20 0.33
CDK5 Q00535 1/20 0.33
CDK5R1 Q15078 1/20 0.33
PDE10A Q9Y233 1/20 0.33
PRUNE1 Q86TP1 1/20 0.32
PKM P14618 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6204274 0.87 CCR4 (0.33) CCNE1CDK2CCNE2
SCHEMBL6203460 0.86 MTOR (0.32) CCNE1CDK2PDE5APDE4DPDE6C
SCHEMBL6204811 0.83 PRUNE1 (0.32) CCNE1CDK2PDE5APDE4DPDE6C
SCHEMBL6203326 0.80 CDK2 (0.38) CCNE1CDK2PDE5APDE4DPDE6C
SCHEMBL6201142 0.79 CDK1 (0.46) CCNE1CDK2PDE5APDE4DPDE6C
SCHEMBL6204605 0.79 TSHR (0.32) CCNE1CDK2PDE5APDE4DPDE6C
SCHEMBL3445281 0.78 CDK2 (0.38) CCNE1CDK2CCNE2CCNT1CDK9
SCHEMBL3445936 0.78 CDK1 (0.41) CCNE1CDK2CCNE2CCNT1CDK9
SCHEMBL6202208 0.78 CDK1 (0.33) CCNE1CDK2PDE5APDE4DPDE6C
SCHEMBL6205419 0.77 CCNE1 (0.36) CCNE1CDK2PDE5APDE4DPDE6C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1534681-A1 SUBSTITUTED QUINOLINE CCR5 RECEPTOR ANTAGONISTS SCHERING AKTIENGESELLSCHAFT (DE) 2005-06-01 EP disclosed
WO-2004002960-A1 SUBSTITUTED QUINOLINE CCR5 RECEPTOR ANTAGONISTS SCHERING AKTIENGESELLSCHAFT (DE) 2004-01-08 WO disclosed